TY - JOUR T1 - Cardiovascular Comorbidities in Psoriasis and Psoriatic Arthritis: Pathogenesis, Consequences for Patient Management, and Future Research Agenda: A Report from the GRAPPA 2009 Annual Meeting JF - The Journal of Rheumatology JO - J Rheumatol SP - 567 LP - 571 DO - 10.3899/jrheum.101124 VL - 38 IS - 3 AU - WOLF-HENNING BOEHNCKE AU - DAFNA D. GLADMAN AU - VINOD CHANDRAN Y1 - 2011/03/01 UR - http://www.jrheum.org/content/38/3/567.abstract N2 - Psoriasis is often associated with other diseases, substantially adding to the patient’s burden of disease. Recent epidemiologic studies have demonstrated an increased cardiovascular morbidity among patients with psoriasis and psoriatic arthritis (PsA), which contributes to their reduced life expectancy. At the meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) adjacent to the International Federation of Psoriasis Associations (IFPA) congress, members discussed the pathogenetic aspects of this association and resulting consequences for the management of patients with psoriasis and PsA. A future research agenda was considered. ER -